01276

恒瑞醫藥

66.400

-2.150-3.14%
Closed16:08 04/17 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE67.000/66.900
TODAY RANGE65.950-67.450
VOL1.45M
MARKET CAP443.70B
52 WEEK RANGE52.500-95.200
AVG VOL (3M)3.29M
% TURNOVER0.02%
TURNOVER96.54M
P/E (TTM)51.971
% RANGE2.24%
EPS(TTM)1.286
P/E(FORWARD)43.865
P/B6.541
BVPS10.221
DIVIDEND0.228
P/S12.670
BETA--
DIV YIELD0.34%
FREE FLOAT MKT CAP17.26B
SHARES OUTSTANDING6.64B
NEXT EARNINGS04/23-04/30
FREE FLOAT258.20M
LOT SIZE200
EX-DATE04/29/2026
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

A

AMGEN-T

04332

0.00%

藥明康德

02359

-5.90%
122.900

海螺創業

00586

-2.35%
11.660

凱萊英

06821

-2.23%
98.450

國藥控股

01099

-2.03%
20.320

白雲山

00874

-0.94%
16.860

麗珠醫藥

01513

-1.36%
28.940

上海醫藥

02607

-1.10%
11.640

S

Shanghai Fosun Pharmaceutical (Group)

02196

-1.47%
20.160

康哲藥業

00867

-0.92%
13.930

06600

--

W

Wuxi Biologics (Cayman)

02269

-3.93%
35.720

中國同輻

01763

-2.69%
18.100

神威藥業

02877

-1.20%
9.880

聯邦制藥

03933

-1.86%
10.040

康臣葯業

01681

-0.18%
16.310

三生製藥

01530

+1.36%
25.260

山東新華製藥股份

00719

-0.78%
6.390

同仁堂國藥

03613

-1.94%
7.570

華潤醫藥

03320

-1.85%
6.380

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.